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ABSTRACT 
 
The purpose of this study is to map non-invasively sentinel lymph nodes (SLNs) and lymphatic vessels of rats in vivo 
using FDA-approved indocyanine green (ICG) and two non-ionizing imaging modalities: volumetric spectroscopic 
photoacoustic (PA) imaging, which measures optical absorption, and planar fluorescence imaging, which measures 
fluorescent emission. SLNs and lymphatic vessels were clearly visible after a 0.2 ml-intradermal-injection of 1 mM ICG 
in both imaging systems. We also imaged deeply positioned lymph nodes in vivo by layering biological tissues on top of 
rats. These two modalities, when used together with ICG, have the potential to map SLNs in axillary staging and to 
study tumor metastasis in breast cancer patients. 
 
Keywords: Photoacoustic tomography, planar fluorescence imaging, sentinel lymph node biopsy, breast cancer, 
axillary lymph node dissection. 
 
INTRODUCTION 
 
To minimize post-operative complications of axillary lymph node dissection (ALND), sentinel lymph node biopsy 
(SLNB), a biopsy of the first draining lymph node in breast cancer region, is the standard process for staging breast 
cancer patients.1 Although current SLNB using methylene blue dye and radioactive materials has an identification rate 
of 90-95% and a sensitivity of 88-95%, this method is ionizing and invasive. Moreover, the false negative rate is still 5-
10%.2,3 In addition, due to the surgical removal of the sentinel lymph node, the SLNB still poses postoperative 
complications like ALND.4 As a minimally invasive method to reduce abovementioned complications, ultrasound-
guided fine needle aspiration biopsy (FNAB) has been tested clinically.5 Yet, ultrasound imaging itself cannot 
distinguish the sentinel lymph node from other lymph nodes. Therefore, there is still a pressing need to develop an 
accurate, reliable, non-ionizing, and non-invasive detection method for lymph node assessment. 
 Photoacoustic (PA) imaging is an optical imaging modality that can provide strong optical contrast and high 
ultrasonic resolution.6,7 The image resolution can be tuned with ultrasonic frequency where diffusive photons reach. 
Moreover, the pixel number, defined as the ratio between the maximum imaging depth and the spatial resolution, 
maintains over 100. In biological tissues, the imaging depth can be up to a few centimeters deep. Methylene blue and 
gold nanoparticles have been applied as lymph node tracers in rats in vivo using PA imaging.8,9 However, the methylene 
blue dye can cause a chemical mastitis as well as photodamage under intense light. Furthermore, gold nanoparticles are 
not yet approved by the FDA for clinical applications. 
We have used FDA-approved indocyanine green (ICG) dye for identifying SLNs and lymphatic vessels in PA 
imaging. Since the fluorescence quantum yield of ICG is about 10%, it can also be used as a contrast agent for 
fluorescence imaging.10 Thus, the purpose of this study was to explore the feasibility of mapping in vivo SLNs and 
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lymphatic vessels with non-invasive and non-ionizing volumetric PA and planar fluorescence imaging, using FDA-
approved ICG in rats. 
 
 
METHODS AND MATERIALS 
 
The experimental schematic of a PA imaging system is described in Fig 1a.11 A tunable dye laser (ND6000, Continuum) 
pumped by a Q-switched Nd:YAG laser (LS-2137, LOTIS) with 6-ns pulse duration and 10-Hz pulse repetition rate was 
utilized. A light wavelength of 668 nm was used for in vivo imaging. The ring-shaped light illumination was formed by 
a concave lens and a spherical conical lens. The light traveled down through an optical condenser, and was coaxially 
aligned with the ultrasound focus in water.12 The light fluence on the skin was 3.4 mJ/cm2, within the current ANSI 
limit.13 We used a single-element 5-MHz ultrasound transducer (V308, Panametrics-NDT) to detect generated PA 
waves. The axial resolution is 144 µm and the lateral resolution is 560 µm. Time-resolved PA amplitudes provide one 
dimensional depth-sensitive images (A-line). Mechanical raster scanning provides two dimensional depth-resolved (B-
scan) and three dimensional images. The scanning stepsizes for the transverse directions (X and Y) were 200 µm and 
400 µm, respectively. For a 25 mm x 30 mm field of view, the acquisition time was 23 minutes. 
The experimental schematic of a planar fluorescence imaging system is shown in Fig 1b. The light beam 
(Thorlabs, 785 nm, 80 mW) was expanded by a concave lens and illuminated rats. A macro lens, a notch-plus filter, and 
a fluorescent bandpass filter were mounted onto the front of a cooled CCD camera (BU401–BR, Andor). Emitted 
fluorescent light was collected by the camera. 
 
 
 
Figure 1: (a) The experimental schematic of volumetric photoacoustic imaging system. (b) The experimental setup of planar 
fluorescence imaging system. DL; dye laser, PCL; plano-concave lens, CL; conical lens, OC; optical condenser, US TX; ultrasound 
transducer, AMP; amplifier, OSC; oscilloscope, COM; computer, PD; photodiode, CCD; CCD camera, LC; laser controller, TC; 
temperature controller, LD; laser diode.  
 
All animal experiments were performed according to the guidelines of the institution on the care and use of 
laboratory animals. A Sprague Dawley rat weighing 250−420 g was given a mixture of ketamine (85 mg/kg) and 
xylazine (15 mg/kg) to anesthetize him. After depilation in the axillary region, the rat was positioned atop a home-made 
holder. During the experiments, the rat was fully anesthetized by a vaporized-isoflurane system (1 L/min oxygen and 
0.75% isoflurane, Euthanex), and the vitals were managed by a pulse oximeter. After image acquisition, the animal was 
euthanized with an overdose of pentobarbital. 0.2 ml of 1-mM ICG was injected intradermally on the left forepaw pad 
of the rat.  
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RESULTS AND DISCUSSIONS 
 
To investigate the feasibility of the use of ICG for volumetric in vivo mapping of SLNs and lymphatic vessels, the left 
axilla of a rat was non-invasively imaged using the PA imaging system. Before the administration of ICG, a control 
image (MAP) was obtained, showing clear vascular structures with good contrast, 7.9 ± 0.8 (Fig 2a). A series of PA 
images was acquired after the injection of ICG. In Fig 2b, the SLN and lymphatic vessels, along with surrounding blood 
vessels, are clearly shown at 0.2 hr post-injection. Figure 2c shows a B-scan image acquired along the cut in Fig. 2b. 
The SLN is positioned about 1.5 mm below the surface. In five PA imaging rats, SLNs were clearly visible with the PA 
signal enhancement of 5.9 ± 1.8 at 0.2 hr post-injection, while lymphatic vessels were seen in four rats with the PA 
signal enhancement of 4.3 ± 0.6. We examined the degradation of spatial resolution in PA images when the imaging 
depth was incremented. After adding one 4 mm thick layer of chicken breast, the depth was increased to 5 – 6 mm. In 
Fig. 2d, the SLN is clearly seen in the B-scan image. The spatial resolution is comparable with that in Fig. 2c.   
 
 
 
Figure 2: In vivo noninvasive PA images of lymphatic systems in rats. (a) Control MAP image acquired before ICG injection in the 
axillary region. (b) PA image at 0.2 hr post-injection. (c) B-scan PA image along the cut in b. (d) B-scan PA image of a SLN with 
additional chicken tissues on top of the rat. BV; blood vessel, SLN; sentinel lymph node, and LV; lymphatic vessel.  
 
By using the planar fluorescence imaging system, the dynamics of ICG uptake on the SLN were monitored in 
Fig. 3. Right after the injection, the SLN started showing up. As time passed, the fluorescent signal within the SLN 
became stronger, and reached a steady state 40 minutes after the injection. The SLN as well as lymphatic vessels are 
clearly shown, which is similar to the PA imaging results. Although planar fluorescence imaging is real-time, it does not 
provide any depth information in the images. The SNR and spatial resolution become worse when the imaging depth 
increases.     
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Figure 3: Planar fluorescence images acquired before injection (control) and 0 minutes, 10 minutes, 20 minutes, and 40 minutes post-
injection of ICG. SLN; sentinel lymph node and LV; lymphatic vessel. 
 
 
CONCLUSIONS 
 
In conclusion, using volumetric spectroscopic PA and planar fluorescence imaging, we have demonstrated the 
feasibility of non-invasive in vivo dual-modality mapping of SLNs and lymphatic vessels with ICG. Unlike gold 
nanoparticles, ICG is an FDA-approved NIR dye for human use. Unlike methylene blue, it has less chemical side effect 
and photodamage. By applying a spectroscopic approach, this PA imaging system is potentially more useful in clinical 
conditions. Images from both techniques clearly show SLNs and lymphatic vessels (Figs 2 and 3). Due to the slow 
image acquisition (23 minutes for a 25 mm x 30 mm field of view), this PA imaging system is not suitable to monitor 
the dynamics of ICG in SLNs and lymphatic vessels, compared to the fluorescence imaging. However, this is not a 
fundamental limitation of PA imaging. The imaging speed can be overcome if an ultrasound array14,15 is used as a 
detector, and/or a high laser pulse repetition rate with a high speed scanning system is used. In summary, non-invasive 
dual-modality (volumetric spectroscopic PA and planar fluorescence imaging) in vivo mapping of SLNs and lymphatic 
vessels using an FDA-approved ICG, has been successfully accomplished in rats. For clinical applications, further 
improvements are required, such as in portability and speed. 
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